Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post‐surgical pain

Documenti analoghi

• Evaluation of the effect of CYP2D6 and OCT1 polymorphisms on the pharmacokinetics of tramadol: Implications for clinical safety and dose rationale in paediatric chronic pain
  di: Paul Healy, et al.
  Pubblicazione: (2024)
• In vitro comparative analysis of metabolic capabilities and inhibitory profiles of selected CYP2D6 alleles on tramadol metabolism
  di: Noor Ahmed Nahid, et al.
  Pubblicazione: (2025)
• Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
  di: Sherouk M. Okda, et al.
  Pubblicazione: (2024)
• Solanidine‐derived CYP2D6 phenotyping elucidates phenoconversion in multimedicated geriatric patients
  di: Jens Andreas Sarömba, et al.
  Pubblicazione: (2025)
• Repeated Intake of Grapefruit Juice Inhibits CYP2B6 , CYP2C9 , CYP2C19 , and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans
  di: Laura Aurinsalo, et al.
  Pubblicazione: (2025)